帕金森病的流行病学
Yoav Ben-Shlomo1, Sirwan Darweesh2, Jorge Llibre-Guerra3
1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Lancet (London, England)
|January 20, 2024
概括
帕金森病的流行病学显示出全球的变化和越来越多的患病率,受环境因素和人口老龄化的影响. 了解这些趋势对于制定有效的预防策略至关重要.
科学领域:
- 流行病学
- 神经退行性疾病
- 公共卫生
背景情况:
- 帕金森病 (PD) 流行病学在时间,地理,种族,年龄和性别上表现出显著的变化.
- 除了人口变化之外,PD的国际患病率正在增加,这可能是由于其他原因的死亡率降低.
- 虽然PD在老年人和男性中更为常见, 怀疑与神经毒素等环境联系, 但发病率趋势, 特别是在女性和低收入国家, 需要进一步调查.
研究的目的:
- 分析帕金森病的流行病变化和趋势.
- 探索可能导致帕金森病风险的环境和遗传因素.
- 突出神经退行性疾病日益重要,需要多方面的预防策略.
主要方法:
- 对帕金森病流行和发病率的流行病学数据的审查.
- 对疾病发生的人口,地理和种族差异的分析.
- 检查假设的环境风险和保护因素,包括杀虫剂和生活方式选择.
主要成果:
- 帕金森病的患病率在全球范围内不断增加,
- 环境因素,如农药暴露,被认为是危险因素,而体力活动和吸烟可能有保护作用.
- 风险的种族差异可能受到医疗保健的影响.
结论:
- 帕金森病是多因素的,涉及复杂的基因环境相互作用.
- 有效的预防需要综合战略来解决初级,二级和三级预防问题.
- 国际研究合作对于全球了解和控制帕金森病至关重要.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
相关概念视频
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
